Trials / Completed
CompletedNCT01022359
Comparison of Tesio and LifeCath Twin Permanent Dialysis Catheters
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Imperial College Healthcare NHS Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare two available types of central venous haemodialysis catheters (lines) - CVCs, and will examine how easy they are to insert, complications, blood flow on dialysis over time, line loss, line clotting and infective events. It will examine whether the LifeCath type of CVC can deliver high blood flow rates from first use after insertion and equivalent function and complication rate to the Tesio type of CVC that is in use in our centre already. Complications relating to dialysis access make up 30% of admissions for haemodialysis patients and so this is a study that could benefit patients and their care providers.
Detailed description
Complications relating to dialysis access make up to 30% of admissions in haemodialysis patients. Comparative studies of complications between dialysis lines can help physicians and patients choose the best CVC type. In addition determining a type of dialysis line that can deliver good blood flows from the outset can minimise length of hospital stay for access creation. This study aims to perform a head-to-head comparison of two very similar (twin catheter) dialysis lines and examine short and long-term function as well as complication rates at our centre.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TesioCath | Insertion of the TesioCath(TM) central venous catheter for haemodialysis vascular access |
| DEVICE | LifeCath Twin | Insertion of the LifeCath Twin central venous catheter for haemodialysis vascular access |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-07-01
- Completion
- 2011-09-01
- First posted
- 2009-12-01
- Last updated
- 2021-04-22
- Results posted
- 2021-04-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01022359. Inclusion in this directory is not an endorsement.